Novo Nordisk Canada Inc.
Registration:
1
of
4
(2023-11-24
to
2023-12-08)
Policies or Program
- Advocate for the implementation of a federal diabetes and obesity strategy.
- Communication around existing drug shortages including Health Canada's monitoring of the worldwide demand for the drug Ozempic.
- Support the establishment of a life sciences strategy in Canada
Policies or Program, Regulation
- Advocate for the establishment of public-private partnerships to support chronic disease prevention.
- Date Modified: